This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Lin Chen, PhD
Peptide Process Chemistry Group Leader at Corden Pharma Colorado


Lin Chen is the Peptide Process Chemistry Group Leader at Corden Pharma Colorado. He obtained his PhD with Professor George Barany from University of Minnesota at Twin Cities. After working on high throughput peptide synthesis at Axcell Biosciences, a Cytogen subsidiary, on the east coast for several years, he joined Roche Colorado Corporation in Boulder to begin his API process development career. He was a Distinguished Scientist when Corden Pharma acquired the Roche facility in Boulder. Dr. Lin Chen has more than 19 years of GMP process development experience, especially in the field of synthetic peptides.

Agenda Sessions

  • Exploration of PAT & Continuous Flow Applications in Peptide Synthesis